CDK4 and diabetes mellitus: Specifically, we showed that Cdk4-E2F3-PGC-1α signals preferentially increase oxidative myofibers in skeletal muscle and stimulate mitochondrial biogenesis and bioenergetics, enabling greater exercise capacity, improved glucose tolerance, and protection from diabetes and obesity.